华恒生物发行H股备案申请材料获中国证监会接收

Core Viewpoint - The company Huaheng Biological (688639.SH) has submitted an application for issuing H-shares and listing on the main board of the Hong Kong Stock Exchange as of September 30, 2025 [1] Group 1 - The company has filed the application with the Hong Kong Stock Exchange and published the relevant application materials on the exchange's website [1] - The company has also submitted the filing application materials to the China Securities Regulatory Commission (CSRC), which has recently accepted the application [1]